ICD-10 Coding for Brain Meningioma(C70.0, C70.0U, D32.0)

Learn about ICD-10 coding for brain meningiomas, including primary codes, documentation requirements, and common pitfalls.

Also known as:
Cerebral MeningiomaIntracranial Meningioma
Related ICD-10 Code Ranges

Complete code families applicable to Brain Meningioma

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
D32.0Benign neoplasm of cerebral meninges
D32.9Benign neoplasm of meninges, unspecified

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutBrain Meningioma

Differential Codes

Alternative codes to consider when ruling out similar conditions

Benign neoplasm of meninges, unspecifiedD32.9

Use when the specific location within the meninges is not documented.

Malignant neoplasm of cerebral meningesC70.0

Use when histopathology confirms malignant behavior (WHO Grade III).

Benign neoplasm of cerebral meningesD32.0

Use when the specific location is confirmed.

Documentation & Coding Risks

Avoid these common issues when documenting Brain Meningioma.

Omitting laterality in documentation

Impact

Clinical: May affect treatment planning and outcomes., Regulatory: Non-compliance with ICD-10 coding standards., Financial: Potential for denied claims or reduced reimbursement.

Mitigation

Implement checklist for documentation completeness, Regular training on ICD-10 requirements

Coding multiple meningiomas as a single code

Impact

Reimbursement: Incorrect coding may lead to reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on tumor prevalence and treatment.

Mitigation

Code each meningioma separately with laterality specified.

Use of unspecified codes

Impact

Frequent use of D32.9 without attempts to specify location may trigger audits.

Mitigation

Encourage providers to document specific tumor locations and query when necessary.

Frequently Asked Questions